Stocksigma LogoStocksigma Logo

Camlin Fine Sciences Reports Q2 FY27 Results; Plans Rights Issue

Camlin Fine Sciences reported Q2 FY27 continuing operations revenue of Rs 4,914.7 mn, up 9.15% YoY, driven by 26% growth in Straights and 25% in Blends

Camlin Fine Sciences Reports Q2 FY27 Results; Plans Rights Issue

Camlin Fine Sciences Ltd 路 Investor Presentation 路 03 Nov 2026, 9:35 pm

Camlin Fine Sciences Reports Q2 FY27 Results; Plans Rights Issue Camlin Fine Sciences reported Q2 FY27 continuing operations revenue of Rs 4,914.7 mn, up 9.15% YoY, driven by 26% growth in Straights and 25% in Blends, offset by a 41% drop in Aroma. Adjusted EBITDA fell to Rs 22.3 mn (0.45% margin) due to elevated raw material costs, freight expenses, and Rs 51 mn idle maintenance at Dahej. Net loss stood at Rs 280.8 mn. The board approved raising up to Rs 2,500 mn via a rights issue, and acquired an additional 11% stake in Vinpai for Rs 201 mn.

Original exchange filing (PDF)

More announcements from Camlin Fine Sciences Ltd

All Camlin Fine Sciences Ltd announcements